Wilder-Smith A - Search Results

1

Markers of dengue severity: a systematic review of cytokines and chemokines.

Lee YH, Leong WY, Wilder-Smith A. Lee YH, et al. J Gen Virol. 2016 Dec;97(12):3103-3119. doi: 10.1099/jgv.0.000637. Epub 2016 Oct 21. J Gen Virol. 2016. PMID: 27902364 Review.

2

Asymptomatic Prenatal Zika Virus Infection and Congenital Zika Syndrome.

Paixao ES, Leong WY, Rodrigues LC, Wilder-Smith A. Paixao ES, et al. Open Forum Infect Dis. 2018 Apr 7;5(4):ofy073. doi: 10.1093/ofid/ofy073. eCollection 2018 Apr. Open Forum Infect Dis. 2018. PMID: 29732381 Free PMC article.

3

Potential for international spread of wild poliovirus via travelers.

Wilder-Smith A, Leong WY, Lopez LF, Amaku M, Quam M, Khan K, Massad E. Wilder-Smith A, et al. BMC Med. 2015 Jun 4;13:133. doi: 10.1186/s12916-015-0363-y. BMC Med. 2015. PMID: 26044336 Free PMC article.

4

Importation of yellow fever into China: assessing travel patterns.

Wilder-Smith A, Leong WY. Wilder-Smith A, et al. J Travel Med. 2017 Jul 1;24(4). doi: 10.1093/jtm/tax008. J Travel Med. 2017. PMID: 28426111

5

Alcohol Use Disorder and Heavy Episodic Drinking in Rural Communities in Cambodia: Risk Factors and Community-Perceived Strategies.

Yeung W, Leong WY, Khoun K, Ong W, Sambi S, Lim SM, Bieber B, Wilder-Smith A. Yeung W, et al. Asia Pac J Public Health. 2015 Nov;27(8):835-47. doi: 10.1177/1010539515607961. Epub 2015 Sep 29. Asia Pac J Public Health. 2015. PMID: 26419634

6

Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine.

Wilder-Smith A, Massad E. Wilder-Smith A, et al. Expert Rev Vaccines. 2016;15(4):437-41. doi: 10.1586/14760584.2016.1143366. Epub 2016 Feb 17. Expert Rev Vaccines. 2016. PMID: 26775653

7

The elusive global burden of dengue.

Wilder-Smith A, Byass P. Wilder-Smith A, et al. Lancet Infect Dis. 2016 Jun;16(6):629-631. doi: 10.1016/S1473-3099(16)00076-1. Epub 2016 Feb 10. Lancet Infect Dis. 2016. PMID: 26874620 No abstract available.

8

Dengue.

Wilder-Smith A, Ooi EE, Horstick O, Wills B. Wilder-Smith A, et al. Lancet. 2019 Jan 26;393(10169):350-363. doi: 10.1016/S0140-6736(18)32560-1. Lancet. 2019. PMID: 30696575 Review.

9

Chymase Level Is a Predictive Biomarker of Dengue Hemorrhagic Fever in Pediatric and Adult Patients.

Tissera H, Rathore APS, Leong WY, Pike BL, Warkentien TE, Farouk FS, Syenina A, Eong Ooi E, Gubler DJ, Wilder-Smith A, St John AL. Tissera H, et al. J Infect Dis. 2017 Nov 27;216(9):1112-1121. doi: 10.1093/infdis/jix447. J Infect Dis. 2017. PMID: 28968807 Free PMC article.

10

Serum chymase levels correlate with severe dengue warning signs and clinical fluid accumulation in hospitalized pediatric patients.

Rathore APS, Senanayake M, Athapathu AS, Gunasena S, Karunaratna I, Leong WY, Lim T, Mantri CK, Wilder-Smith A, St John AL. Rathore APS, et al. Sci Rep. 2020 Jul 16;10(1):11856. doi: 10.1038/s41598-020-68844-z. Sci Rep. 2020. PMID: 32678248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

405 results

Search Page